Driver genes/alterations, such as MYCN, 1p/11q deletion, ALK, ATRX and TERT, are characterized in high-risk neuroblastoma by previous studies, however, it is difficult to further stratify the high-risk neuroblastoma at molecular level. This evidence concerns the gene MYCN and neuroblastoma.